Clinical Trial: Kisspeptin Administration Subcutaneously to Patients With IHH
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hypogonadotropic Hypogonadism
Study Type: INTERVENTIONAL
Official Title: Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Brief Summary:
We are recruiting men and women with Idiopathic Hypogonadotropic Hypogonadism (IHH).Kisspeptin will be administered subcutaneously (SC) for 2-weeks in a pulsatile fashion.Ultrasound monitoring of ovarian follicular growth (for women) and frequent blood sampling (q10 minutes for up to 70 minutes) will be performed to assess the physiologic response to kisspeptin over time.
Read more